Literature DB >> 19553332

A New World primate deficient in tetherin-mediated restriction of human immunodeficiency virus type 1.

Swee Kee Wong1, Michelle Connole, JoAnne S Sullivan, Hyeryun Choe, Angela Carville, Michael Farzan.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) does not replicate in primary cells of New World primates. To better understand this restriction, we expressed owl monkey (Aotus nancymaae) CD4 and CXCR4 in the owl monkey kidney cell line, OMK. An HIV-1 variant modified to evade the owl monkey restriction factor TRIM-cyp replicated efficiently in these cells but could not replicate in primary A. nancymaae CD4-positive T cells. To understand this difference, we examined APOBEC3G and tetherin orthologs from OMK cells and primary A. nancymaae cells. We observed that OMK cells expressed substantially lower levels of APOBEC3G than did A. nancymaae cells. A. nancymaae, but not marmoset (Callithrix jacchus), APOBEC3G was partially downregulated by HIV-1 vif and reduced but did not abolish HIV-1 replication when stably expressed in OMK cells. The functional difference between A. nancymaae and marmoset APOBEC3Gs mapped to residue 128, previously shown to distinguish African green monkey from human APOBEC3G. We also characterized tetherin orthologs from OMK and A. nancymaae cells. The A. nancymaae tetherin ortholog, but not OMK tetherin, prevented HIV-1 release. Alteration of threonine 181 of OMK tetherin rescued its function and its efficient N glycosylation. All alleles of Aotus lemurinus griseimembra examined, but none of A. nancymaae or Aotus vociferans, encoded this nonfunctional tetherin ortholog. Our data indicate that HIV-1 replication in owl monkeys is not restricted at entry but can be limited by APOBEC3G and tetherin. Further, A. lemurinus griseimembra does not restrict HIV-1 replication via tetherin, a property likely useful for the study of tetherin-restricted viruses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553332      PMCID: PMC2738210          DOI: 10.1128/JVI.00112-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Authors:  Sébastien Nisole; Clare Lynch; Jonathan P Stoye; Melvyn W Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

Review 2.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

3.  Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence.

Authors:  A A Bukovsky; A Weimann; M A Accola; H G Göttlinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Interactions between human cyclin T, Tat, and the transactivation response element (TAR) are disrupted by a cysteine to tyrosine substitution found in mouse cyclin T.

Authors:  K Fujinaga; R Taube; J Wimmer; T P Cujec; B M Peterlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

5.  Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1.

Authors:  David M Sayah; Elena Sokolskaja; Lionel Berthoux; Jeremy Luban
Journal:  Nature       Date:  2004-07-07       Impact factor: 49.962

6.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein.

Authors:  M E Garber; P Wei; V N KewalRamani; T P Mayall; C H Herrmann; A P Rice; D R Littman; K A Jones
Journal:  Genes Dev       Date:  1998-11-15       Impact factor: 11.361

7.  A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor.

Authors:  Hal P Bogerd; Brian P Doehle; Heather L Wiegand; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-03       Impact factor: 11.205

8.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody.

Authors:  P D Kwong; R Wyatt; J Robinson; R W Sweet; J Sodroski; W A Hendrickson
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

9.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

10.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  18 in total

1.  C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motif.

Authors:  Amy J Andrew; Sandra Kao; Klaus Strebel
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  HIV-1 Adapts To Replicate in Cells Expressing Common Marmoset APOBEC3G and BST2.

Authors:  Alberto Fernández-Oliva; Andrés Finzi; Hillel Haim; Luis Menéndez-Arias; Joseph Sodroski; Beatriz Pacheco
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

3.  Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.

Authors:  Christine Goffinet; Sarah Schmidt; Christian Kern; Lena Oberbremer; Oliver T Keppler
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

4.  Identification of Owl Monkey CD4 Receptors Broadly Compatible with Early-Stage HIV-1 Isolates.

Authors:  Nicholas R Meyerson; Amit Sharma; Gregory K Wilkerson; Julie Overbaugh; Sara L Sawyer
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

5.  Identification, classification and evolution of owl monkeys (Aotus, Illiger 1811).

Authors:  Albert N Menezes; Cibele R Bonvicino; Hector N Seuánez
Journal:  BMC Evol Biol       Date:  2010-08-12       Impact factor: 3.260

Review 6.  The great escape: viral strategies to counter BST-2/tetherin.

Authors:  Janet L Douglas; Jean K Gustin; Kasinath Viswanathan; Mandana Mansouri; Ashlee V Moses; Klaus Früh
Journal:  PLoS Pathog       Date:  2010-05-13       Impact factor: 6.823

Review 7.  Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.

Authors:  Andrey Tokarev; Mark Skasko; Kathleen Fitzpatrick; John Guatelli
Journal:  AIDS Res Hum Retroviruses       Date:  2009-12       Impact factor: 2.205

8.  Tetherin Antagonism by HIV-1 Group M Nef Proteins.

Authors:  Juan F Arias; Marta Colomer-Lluch; Benjamin von Bredow; Justin M Greene; Julie MacDonald; David H O'Connor; Ruth Serra-Moreno; David T Evans
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

9.  Early Vertebrate Evolution of the Host Restriction Factor Tetherin.

Authors:  Elena Heusinger; Silvia F Kluge; Frank Kirchhoff; Daniel Sauter
Journal:  J Virol       Date:  2015-09-23       Impact factor: 5.103

10.  Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.

Authors:  Benjamin von Bredow; Juan F Arias; Lisa N Heyer; Matthew R Gardner; Michael Farzan; Eva G Rakasz; David T Evans
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.